Cite
HARVARD Citation
Sanchez-Garcia, J. et al. (2018). Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia. Leukemia & lymphoma. 59 (5), pp. 1095-1104. [Online].